1. Lewis JD, Lichtenstein GR, Stein RB, Deren JJ, Judge TA, Fogt F, Furth EE, Demissie EJ, Hurd LB, Su CG. An open-label trial of the PPAR-gamma ligand rosiglitazone for active ulcerative colitis. Am J Gastroenterol 2001;96:3323-3328.
2. Ou-Yang Q, Pan GZ, Wen ZH, Wan XH, Hu RW, Lin SR, Hu PJ. Suggested guideline for the diagnosis and treatment of inflammatory bowel disease. Chin J Dig Dis 2001;21:236-239.
3. Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med 1987;317:1625-1629.
4. Truelove SC, Richards WC. Biopsy studies in ulcerative colitis. Br Med J 1956;1:1315-1318.
5. Dubuquoy L, Jansson EA, Deeb S, Rakotobe S, Karoui M, Colombel JF, Auwerx J, Pettersson S, Desreumaux P. Impaired expression of peroxisome proliferator-activated receptor gamma in ulcerative colitis. Gastroenterology 2003;124:1265-1276.